Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Perimeter Medical Imaging AIFRA:4PC +0.63%32 Equity-to-Asset is 0.35 as of Mar. 2026, which is 54% below its 10-year median of 0.76. GuruFocus rates FRA:4PC with a GF Score™ of 32/100 and a GF Value™ of €0.54 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Perimeter Medical Imaging AI ranks worse than 79.74% on this metric.
The historical rank and industry rank for Perimeter Medical Imaging AI's Equity-to-Asset or its related term are showing as below:
FRA:4PC'
s Equity-to-Asset Range Over the Past 10 Years
Min: -6.45 Med: 0.76 Max: 0.89
Current: 0.35
During the past 7 years, the highest Equity to Asset Ratio of Perimeter Medical Imaging AI was 0.89. The lowest was -6.45. And the median was 0.76.
FRA:4PC's Equity-to-Asset is ranked worse than 79.74% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs FRA:4PC: 0.35
Perimeter Medical Imaging AI (FRA:4PC) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Perimeter Medical Imaging AI Equity-to-Asset Related Terms
Perimeter Medical Imaging AI Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perimeter Medical Imaging AI Equity-to-Asset Chart
FRA:4PC vs ABT, SYK, MDT: Equity-to-Asset Comparison
For the Medical Devices subindustry, Perimeter Medical Imaging AI's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perimeter Medical Imaging AI Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Perimeter Medical Imaging AI's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Perimeter Medical Imaging AI's Equity-to-Asset falls into.
Perimeter Medical Imaging AI Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Perimeter Medical Imaging AI's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perimeter Medical Imaging AI (FRA:4PC) has a Equity-to-Asset of 0.35 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Perimeter Medical Imaging AI and its competitors. This is 54% below median its historical median of 0.76. According to the industry distribution chart, Perimeter Medical Imaging AI ranks #681 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 79.7%.
Is Perimeter Medical Imaging AI's Equity-to-Asset too high?
Perimeter Medical Imaging AI's current Equity-to-Asset of 0.35 is 54% below median its 10-year median of 0.76. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Perimeter Medical Imaging AI's value of 0.35 is 45.3% below this industry median. Based on the distribution chart, Perimeter Medical Imaging AI ranks #681 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Perimeter Medical Imaging AI has a GF Score™ of 32/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Perimeter Medical Imaging AI's Equity-to-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Perimeter Medical Imaging AI ranks #681 out of 854 companies for Equity-to-Asset. This places Perimeter Medical Imaging AI in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Perimeter Medical Imaging AI's value of 0.35 is 45.3% below this benchmark. While the company's 10-year median is 0.76 vs. the industry median of 0.64, Perimeter Medical Imaging AI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Perimeter Medical Imaging AI's current Equity-to-Asset of 0.35 is 45.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Perimeter Medical Imaging AI and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perimeter Medical Imaging AI's current Equity-to-Asset is 0.35, which is 54% below median its own 10-year median of 0.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perimeter Medical Imaging AI stock overvalued right now?
Based on GuruFocus' analysis, Perimeter Medical Imaging AI (FRA:4PC) is currently considered Possible Value Trap. The stock's GF Value™ is €0.54, compared to a current price of €0.16 — trading 70.4% below its estimated fair value. The current Equity-to-Asset is 0.35, which is 54% below median its 10-year median of 0.76 and 45.3% below the Medical Devices & Instruments industry median of 0.64. Perimeter Medical Imaging AI's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Perimeter Medical Imaging AI (FRA:4PC), the current Equity-to-Asset is 0.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Perimeter Medical Imaging AI (FRA:4PC) Overvalued in 2026?
Based on GuruFocus' analysis, Perimeter Medical Imaging AI stock appears to be undervalued.
The current stock price of €0.16 is trading 70.4% below its estimated GF Value™ of €0.54.
GuruFocus considers Perimeter Medical Imaging AI to be Possible Value Trap.
Key valuation signals for FRA:4PC:
Equity-to-Asset: 0.35 (54% below median its 10-year median of 0.76)
GF Value™: €0.54 vs. price of €0.16 (70.4% below fair value)
Industry Position: 45.3% below the Medical Devices & Instruments median (#681 of 854)
No single metric tells the full story. See the FRA:4PC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Perimeter Medical Imaging AI Inc is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, imaging tools to address high unmet medical needs. Its flagship product, Perimeter S-Series OCT (Optical Coherence Tomography) is a pioneering medical imaging system that delivers ultra-high-resolution margin visualization of excised tissue specimens in the operating room.
32GF Score
Get the complete analysis for FRA:4PC
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4PC has been successfully added to your 
